Presentation THT 2022 Should SGLT2 Inhibitors Be Started in the Hospital or in the Ambulatory Setting? Presenter: Piotr Ponikowski February 01, 2022 REGISTER for free or LOG IN to view this content Heart Failure THT 2022 Heart Failure Up Next Presentation THT 2022 PRO - LA decompression is unnecessary in the era of SGLT2 inhibitors and ARNI's! Presenter: Alanna Morris February 01, 2022 More slides + Presentation THT 2022 CON - PRO - LA decompression is unnecessary in the era of SGLT2 inhibitors and ARNI's! Presenter: Sanjiv Shah February 01, 2022 Presentation THT 2022 PRO - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts! Presenter: Roham Zamanian February 01, 2022 We Recommend Disclosures NULL
Presentation THT 2022 PRO - LA decompression is unnecessary in the era of SGLT2 inhibitors and ARNI's! Presenter: Alanna Morris February 01, 2022
Presentation THT 2022 CON - PRO - LA decompression is unnecessary in the era of SGLT2 inhibitors and ARNI's! Presenter: Sanjiv Shah February 01, 2022
Presentation THT 2022 PRO - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts! Presenter: Roham Zamanian February 01, 2022